Update focuses on the evaluation, management, and monitoring of those at risk for, or living with, dyslipidemia.
Alexander B. Olawaiye, MD, shares how relacorilant’s recent approval might change the treatment landscape for ovarian cancer.
As wildfire smoke becomes an increasingly common consequence of climate change, clinicians are facing new challenges in ...
A prospective survey study presented at the 2026 ASCO Annual Meeting highlighted the heterogeneity of patient experiences ...
"Food becomes medicine when it's integrated thoughtfully into comprehensive, evidence-based care," says Christina Sheil, MD.
Hao Yu, PhD, discusses his team’s findings showing the 2025 immigration ban could worsen clinician shortages in underserved ...
Robert J. Fontana, MD, and Kenneth D. Rothstein, MD, share how they deliver self-management education to patients with MASLD.
Looking for a laugh? This week’s medical cartoon features a famous explorer dealing with persistent directional dysregulation ...
Amram Kahn, MD, shares strategies for reconciling disparate clinical recommendations to optimize medication regimens for ...
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) may be prescribed to people with heart failure, chronic kidney disease, ...
Luana Colloca, MD, PhD, and Chris Reist, MD, comment on how clinicians can use placebo and nocebo effects to improve care.
In a review of nearly 2,000 cases involving patients undergoing emergency surgery, factors independently associated with increased risk for ICU admission included advanced age, trauma-related ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results